Document is current
Any future updates will be listed below
-
Authors
Papiol, Sergi https://orcid.org/0000-0001-9366-8728
Keeser, Daniel https://orcid.org/0000-0002-0244-1024
Hasan, Alkomiet
Schneider-Axmann, Thomas
Raabe, Florian
Degenhardt, Franziska
Rossner, Moritz J.
Bickeböller, Heike
Cantuti-Castelvetri, Ludovico
Simons, Mikael
Wobrock, Thomas
Schmitt, Andrea
Malchow, Berend
Falkai, Peter
- License Information
-
More Information
Article History
Received: 20 May 2019
Revised: 10 September 2019
Accepted: 3 October 2019
First Online: 11 November 2019
Conflict of interest
: S.P., D.K., T.S.-A., H.B., F.R., M.J.R. and B.M. report no conflicts of interest. A.H. has received paid speakerships from Lundbeck, Janssen, Otsuka, Desitin, and Pfizer and was a member of the advisory boards of Lunbeck, Janssen, Roche, and Otsuka. T.W. has received speaker honoraria from Alpine Biomed, Astra Zeneca, Bristol-Myers Squibb, Eli Lilly, I3G, Janssen-Cilag, Novartis, Lundbeck, Roche, Sanofi-Aventis, Otsuka, and Pfizer, was a member of the advisory boards of Janssen-Cilag and Otsuka/Lundbeck and has received restricted research grants from AstraZeneca, Cerbomed, I3G, and AOK (health insurance company). A.S. has been an honorary speaker for TAD Pharma and Roche and a member of the advisory board for Roche. P.F. has received grants and served as consultant, advisor, or CME speaker for the following entities: Abbott, GlaxoSmithKline, Janssen, Essex, Lundbeck, Otsuka, Gedeon Richter, Servier, Takeda, the German Ministry of Science, and the German Ministry of Health.
